Alexander Gottschalk, MD, PhD

Title(s)Professor, Radiation Oncology
SchoolSchool of Medicine
Address1600 Divisadero, #H1014
San Francisco CA 94115
Phone415-353-7185
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of ChicagoM.D.1996School of Medicine
    Collapse Awards and Honors
    UCSF2009  - 2010Educator of the Year
    UCSF2012  - 2013Lifetime Teaching Award
    UCSF2012  - 2013Commitment to Patient Care Award

    Collapse Overview 
    Collapse Overview
    I am involved with the Urologic, Thoracic, Orthopedic and Gastrointestinal Oncology programs at UCSF. I spend 4 days per week providing clinical coverage for the above programs program. On average, I see 6 new patient consultations per week and 15 patients on treatment. I am responsible for patient simulations, treatment planning, supervision of external-beam radiation therapy, on-treatment visits, and follow-up visits. In addition, I am involved in the brachytherapy, intra-operative radiation therapy and stereotactic body radiotherapy programs. I attend tumor boards for GU, Thoracic, GI, orthopedic oncology programs and at the Veterans Administration Hospital. I work very closely with radiation oncology residents and medical students in all the above activities. I am the Director of the CyberKnife Radiosurgery Program at UCSF and proctor other faculty in this area. As Vice Chair of clinical services I over see clinical operations at the Mount Zion site, and over see the site directors at both the Parnassus Mission Bay and Washington Hospital.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Adv Radiat Oncol. 2022 Sep-Oct; 7(5):100941. Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG. PMID: 35847550; PMCID: PMC9280039.
      View in: PubMed   Mentions: 2  
    2. Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):429-437. Chen WC, Li Y, Lazar A, Altun A, Descovich M, Nano T, Ziemer B, Sudhyadhom A, Cunha A, Thomas H, Gottschalk A, Hsu IC, Roach M. PMID: 33385496.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    3. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial. JAMA Netw Open. 2020 09 01; 3(9):e209750. Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS. PMID: 32997124; PMCID: PMC7527870.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    4. Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients. Int J Radiat Oncol Biol Phys. 2020 05 01; 107(1):48-61. Chen WC, Baal JD, Baal U, Pai J, Gottschalk A, Boreta L, Braunstein SE, Raleigh DR. PMID: 32001383; PMCID: PMC8177042.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    5. Using a Robust and Sensitive GFP-Based cGMP Sensor for Real-Time Imaging in Intact Caenorhabditis elegans. Genetics. 2019 09; 213(1):59-77. Woldemariam S, Nagpal J, Hill T, Li J, Schneider MW, Shankar R, Futey M, Varshney A, Ali N, Mitchell J, Andersen K, Barsi-Rhyne B, Tran A, Costa WS, Krzyzanowski MC, Yu YV, Brueggemann C, Hamilton OS, Ferkey DM, VanHoven M, Sengupta P, Gottschalk A, L'Etoile N. PMID: 31331946; PMCID: PMC6727795.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    6. Dedicated Diagnostic Radiology/Radiation Oncology Rounds: Added Value Beyond Traditional Tumor Boards. Curr Probl Diagn Radiol. 2020 Jul - Aug; 49(4):248-253. Kallianos KG, Muhoozi BN, Gottschalk A, Yom SS, Chan JW, Henry TS, Elicker BM, Ordovas KG, Naeger DM. PMID: 31153661.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy. J Contemp Brachytherapy. 2018 Jun; 10(3):193-201. Chapman CH, Braunstein SE, Pouliot J, Noworolski SM, Weinberg V, Cunha A, Kurhanewicz J, Gottschalk AR, Roach MI, Hsu IC. PMID: 30038638; PMCID: PMC6052382.
      View in: PubMed   Mentions: 8  
    9. Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy. J Appl Clin Med Phys. 2018 Jul; 19(4):48-57. Chapman CH, McGuinness C, Gottschalk AR, Yom SS, Garsa AA, Anwar M, Braunstein SE, Sudhyadhom A, Keall P, Descovich M. PMID: 29700954; PMCID: PMC6036380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):437-454. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. PMID: 29114613; PMCID: PMC5605284.
      View in: PubMed   Mentions: 10  
    11. ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol. 2017 02; 40(1):1-10. McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ, Expert Panel on Radiation OncologyProstate. PMID: 28059930.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Respiration-Induced Intraorgan Deformation of the Liver: Implications for Treatment Planning in Patients Treated With Fiducial Tracking. Technol Cancer Res Treat. 2017 Dec; 16(6):776-782. Paulsson AK, Yom SS, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang AJ, Descovich M. PMID: 28071340; PMCID: PMC5762032.
      View in: PubMed   Mentions: 4     Fields:    
    13. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer. Brachytherapy. 2017 Mar - Apr; 16(2):266-276. Davis BJ, Taira AV, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Showalter TN, Vapiwala N. PMID: 27964905.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):62-84. Expert Panel on Radiation Oncology-Prostate:, Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. PMID: 28740916; PMCID: PMC5514238.
      View in: PubMed   Mentions: 10  
    15. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 27711167; PMCID: PMC5053526.
      View in: PubMed   Mentions:    Fields:    
    16. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity. J Surg Oncol. 2016 Dec; 114(7):838-847. Woodard GA, Crockard JC, Clary-Macy C, Zoon-Besselink CT, Jones K, Korn WM, Ko AH, Gottschalk AR, Rogers SJ, Jablons DM. PMID: 27569043.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    17. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e109-e116. Zhang L, Johnson J, Gottschalk AR, Chang AJ, Hsu IC, Roach M, Seymour ZA. PMID: 28274401.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer. Technol Cancer Res Treat. 2017 04; 16(2):178-187. Wahl M, Descovich M, Shugard E, Pinnaduwage D, Sudhyadhom A, Chang A, Roach M, Gottschalk A, Chen J. PMID: 27199276; PMCID: PMC5616028.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. An Evaluation of Robotic and Conventional IMRT for Prostate Cancer: Potential for Dose Escalation. Technol Cancer Res Treat. 2017 06; 16(3):267-275. Pinnaduwage DS, Descovich M, Lometti MW, Varad B, Roach M, Gottschalk AR. PMID: 27037301; PMCID: PMC5616040.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer. Radiat Oncol. 2016 Jan 21; 11:8. Anwar M, Weinberg V, Seymour Z, Hsu IJ, Roach M, Gottschalk AR. PMID: 26792201; PMCID: PMC4721063.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    22. Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients. J Appl Clin Med Phys. 2015 09 08; 16(5):284–295. McGuinness CM, Gottschalk AR, Lessard E, Nakamura JL, Pinnaduwage D, Pouliot J, Sims C, Descovich M. PMID: 26699309; PMCID: PMC5690182.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    23. Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma. Sarcoma. 2015; 2015:913565. Tinkle CL, Weinberg V, Braunstein SE, Wustrack R, Horvai A, Jahan T, O'Donnell RJ, Gottschalk AR. PMID: 26346118; PMCID: PMC4546758.
      View in: PubMed   Mentions: 6  
    24. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. PMID: 26198421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Obesity in regional anesthesia--a risk factor for peripheral catheter-related infections. Acta Anaesthesiol Scand. 2015 Sep; 59(8):1038-48. Bomberg H, Albert N, Schmitt K, Gräber S, Kessler P, Steinfeldt T, Hering W, Gottschalk A, Standl T, Stork J, Meißner W, Teßmann R, Geiger P, Koch T, Spies CD, Volk T, Kubulus C. PMID: 26040788.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-e472. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. PMID: 25795252.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: insights from lung tumor patients treated with robotic radiosurgery. Med Phys. 2015 Mar; 42(3):1280-7. Descovich M, McGuinness C, Kannarunimit D, Chen J, Pinnaduwage D, Pouliot J, Kased N, Gottschalk AR, Yom SS. PMID: 25735283.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer. Oncology (Williston Park). 2014 Dec; 28(12):1125-30, 1132-6. Gustafson GS, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Hsu IC, Lloyd S, Mclaughlin PW, Merrick GS, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ. PMID: 25510812.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015 Feb; 14(1):49-60. Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS. PMID: 24325136.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. [Differences of analgesic efficacy and complication rates between ultrasound and nervestimulator guided peripheral nerve catheters : Database analysis on patient-relevant target parameters]. Anaesthesist. 2014 Nov; 63(11):825-31. Schnabel A, Middendorf B, Boschin MG, Gottschalk A, Van Aken H, Zahn PK, Pogatzki-Zahn EM. PMID: 25227880.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun; 6(2):143-53. Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M. PMID: 25097554; PMCID: PMC4105644.
      View in: PubMed   Mentions: 2  
    32. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2014 Jun; 37(3):278-88. Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ, American College of Radiology, Expert Panel on Radiation OncologyProstate. PMID: 25180754.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Response to Drs Rogers, Hayes, and Demanes. Brachytherapy. 2014 Sep-Oct; 13(5):523-5. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G, Expert Panel on Radiation Oncology–Prostate. PMID: 24880587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Commentary on "Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer." Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Harvard Radiation Oncology Program, Boston, MA.: Cancer 2013;119(9):1729-35. doi: 10.1002/cncr.27956. [Epub 2013 Feb 22]. Urol Oncol. 2014 Apr; 32(3):373-4. Gottschalk A. PMID: 24679463.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Commentary on "Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus." Kalakota K, Liauw SL, Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL.: Urology 2013;81(6):1196-201. doi: 10.1016/j.urology.2013.01.047. [Epub 2013 Mar 26]. Urol Oncol. 2014 Apr; 32(3):374. Gottschalk A. PMID: 24679464.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    36. Commentary on "A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma." Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Victoria, Australia.: BJU Int 2012;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. [Epub 2012 Oct 29]. Urol Oncol. 2014 Apr; 32(3):374-5. Gottschalk A. PMID: 24679465.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. The Long-Term Clinical Outcomes Following Autogenous Bone Grafting for Large-Volume Defects of the Knee: 12- to 21-Year Follow-Up. Cartilage. 2014 Apr; 5(2):86-96. Johnson LL, Delano M, Spector M, Pittsley A, Gottschalk A. PMID: 26069688; PMCID: PMC4297077.
      View in: PubMed   Mentions: 5     Fields:    
    38. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 24594774; PMCID: PMC3940667.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    39. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014 Feb 02; 9:42. Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M, Gottschalk A. PMID: 24484652; PMCID: PMC3923240.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    40. Commentary on "secondary cancers after intensity-modulated radiotherapy, brachytherapy, and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention." Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.: BJU Int 2012;110:1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. [Epub 2012 Aug 13]. Urol Oncol. 2014 Feb; 32(2):209. Gottschalk A. PMID: 24445290.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers. J Radiosurg SBRT. 2014; 3(1):67-79. Braunstein SE, Dionisio SA, Lometti MW, Pinnaduwage DS, Chuang CF, Yom SS, Gottschalk AR, Descovich M. PMID: 29296387; PMCID: PMC5725332.
      View in: PubMed   Mentions:
    42. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):27-31. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. PMID: 24368283.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. PMID: 24231238; PMCID: PMC4081029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife. J Appl Clin Med Phys. 2013 Sep 06; 14(5):162-72. Descovich M, Carrara M, Morlino S, Pinnaduwage DS, Saltiel D, Pouliot J, Nash MB, Pignoli E, Valdagni R, Roach M, Gottschalk AR. PMID: 24036869; PMCID: PMC5714582.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):324-9. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. PMID: 23474112.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic Health
    46. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance. J Am Coll Radiol. 2013 Feb; 10(2):83-92. Eberhardt SC, Carter S, Casalino DD, Merrick G, Frank SJ, Gottschalk AR, Leyendecker JR, Nguyen PL, Oto A, Porter C, Remer EM, Rosenthal SA. PMID: 23374687.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    47. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. PMID: 23289478.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012 Aug; 109(2):253-9. Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. PMID: 22705968.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    49. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):370-7. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. PMID: 22672747.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    50. Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy. Phys Med Biol. 2011 Dec 21; 56(24):7767-75. Shiao SL, Sahgal A, Hu W, Jabbari S, Chuang C, Descovich M, Hsu IC, Gottschalk AR, Roach M, Ma L. PMID: 22107791.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Caenorhabditis elegans selects distinct crawling and swimming gaits via dopamine and serotonin. Proc Natl Acad Sci U S A. 2011 Oct 18; 108(42):17504-9. Vidal-Gadea A, Topper S, Young L, Crisp A, Kressin L, Elbel E, Maples T, Brauner M, Erbguth K, Axelrod A, Gottschalk A, Siegel D, Pierce-Shimomura JT. PMID: 21969584; PMCID: PMC3198358.
      View in: PubMed   Mentions: 72     Fields:    Translation:AnimalsCells
    52. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):228-34. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. PMID: 21183287.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    53. Controversies in diagnosis of pulmonary embolism. Clin Appl Thromb Hemost. 2011 Apr; 17(2):140-9. Stein PD, Sostman HD, Dalen JE, Bailey DL, Bajc M, Goldhaber SZ, Goodman LR, Gottschalk A, Hull RD, Matta F, Pistolesi M, Tapson VF, Weg JG, Wells PS, Woodard PK, Consensus Group. PMID: 21159701.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):222-7. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. PMID: 21163586.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    55. Patellar metastatic melanoma in a 13-year-old boy. Am J Orthop (Belle Mead NJ). 2010 Dec; 39(12):582-6. Burk TF, Horvai AE, Gottschalk AR, Leong SP, Kashani-Sabet M, Goldsby RE, Law J, O'Donnell RJ. PMID: 21720575.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam. Med Phys. 2010 Apr; 37(4):1737-41. Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom SS. PMID: 20443494.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    57. A diamond target for megavoltage cone-beam CT. Med Phys. 2010 Mar; 37(3):1246-53. Sawkey D, Lu M, Morin O, Aubin M, Yom SS, Gottschalk AR, Bani-Hashemi A, Faddegon BA. PMID: 20384262.
      View in: PubMed   Mentions: 3     Fields:    
    58. Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):58-63. Hossain S, Xia P, Huang K, Descovich M, Chuang C, Gottschalk AR, Roach M, Ma L. PMID: 20133073.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    59. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):36-42. Jabbari S, Weinberg VK, Shinohara K, Speight JL, Gottschalk AR, Hsu IC, Pickett B, McLaughlin PW, Sandler HM, Roach M. PMID: 19409729.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    60. [Pain and quality of life for living donors after nephrectomy]. Schmerz. 2009 Oct; 23(5):502-9. Gottschalk A, Götz J, Zenz M. PMID: 19763631.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Nonrandom intrafraction target motions and general strategy for correction of spine stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1261-5. Ma L, Sahgal A, Hossain S, Chuang C, Descovich M, Huang K, Gottschalk A, Larson DA. PMID: 19647951.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    62. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy. 2009 Oct-Dec; 8(4):339-44. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M, Shinohara K. PMID: 19428310.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):583-92. Cheung J, Aubry JF, Yom SS, Gottschalk AR, Celi JC, Pouliot J. PMID: 19345518.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    64. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009 Sep; 104(5):600-4. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. PMID: 19245439.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    65. Correction of megavoltage cone-beam CT images of the pelvic region based on phantom measurements for dose calculation purposes. J Appl Clin Med Phys. 2009 Jan 27; 10(1):33-42. Aubry JF, Cheung J, Morin O, Gottschalk A, Beaulieu L, Pouliot J. PMID: 19223832; PMCID: PMC5720499.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys. 2008 Sep; 35(9):4041-8. Hossain S, Xia P, Chuang C, Verhey L, Gottschalk AR, Mu G, Ma L. PMID: 18841856.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    67. Sci-Thurs PM: Delivery-12: Correction and calibration of megavoltage cone-beam CT images for the calculation of the dose of the day. Med Phys. 2008 Jul; 35(7Part2):3401. Aubry JF, Cheung J, Yom S, Gottschalk A, Aubin M, Morin O, Descovich M, Beaulieu L, Pouliot J. PMID: 28512819.
      View in: PubMed   Mentions:    Fields:    
    68. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):69-77. Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Pickett B, Hsu IC, Speight J, Roach M. PMID: 18342454.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    69. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med. 2007 Oct; 120(10):871-9. Stein PD, Beemath A, Matta F, Weg JG, Yusen RD, Hales CA, Hull RD, Leeper KV, Sostman HD, Tapson VF, Buckley JD, Gottschalk A, Goodman LR, Wakefied TW, Woodard PK. PMID: 17904458; PMCID: PMC2071924.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    70. Very low probability interpretation of V/Q lung scans in combination with low probability objective clinical assessment reliably excludes pulmonary embolism: data from PIOPED II. J Nucl Med. 2007 Sep; 48(9):1411-5. Gottschalk A, Stein PD, Sostman HD, Matta F, Beemath A. PMID: 17785726.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys. 2007 May; 34(5):1819-27. Morin O, Gillis A, Descovich M, Chen J, Aubin M, Aubry JF, Chen H, Gottschalk AR, Xia P, Pouliot J. PMID: 17555263.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    72. Usefulness of multidetector spiral computed tomography according to age and gender for diagnosis of acute pulmonary embolism. Am J Cardiol. 2007 May 01; 99(9):1303-5. Stein PD, Beemath A, Quinn DA, Olson RE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV, Sostman HD, Weg JG, Woodard PK. PMID: 17478162.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    73. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):610-9. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M. PMID: 17236978.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    74. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology. 2007 Jan; 242(1):15-21. Stein PD, Woodard PK, Weg JG, Wakefield TW, Tapson VF, Sostman HD, Sos TA, Quinn DA, Leeper KV, Hull RD, Hales CA, Gottschalk A, Goodman LR, Fowler SE, Buckley JD, PIOPED II Investigators. PMID: 17185658.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    75. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1106-12. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. PMID: 17197119.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    76. Comparative study of different concentrations of prilocaine and ropivacaine for intraoperative axillary brachial plexus block. Eur J Anaesthesiol. 2006 Jun; 23(6):481-6. Freitag M, Zbieranek K, Gottschalk A, Bubenheim M, Winter R, Tuszynski S, Standl TG. PMID: 16507196.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Clinical outcomes of intraoperative radiation therapy for extremity sarcomas. Sarcoma. 2006; 2006(1):91671. Tran QN, Kim AC, Gottschalk AR, Wara WM, Phillips TL, O'donnell RJ, Weinberg V, Haas-Kogan DA. PMID: 17040093; PMCID: PMC1557794.
      View in: PubMed   Mentions: 8  
    78. Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1221-7. Gottschalk AR, Doan A, Nakamura JL, Stokoe D, Haas-Kogan DA. PMID: 16253776.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    79. [Infratentorial progressive multifocal leukoencephalopathy in a patient with pulmonary sarcoidosis]. Rofo. 2005 Nov; 177(11):1583-5. Gottschalk A, Danz B, Völk M. PMID: 16302142.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. Master VA, Gottschalk AR, Kane C, Carroll PR. PMID: 16006867.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    81. Inhibition of phosphatidylinositol-3-kinase causes cell death through a protein kinase B (PKB)-dependent mechanism and growth arrest through a PKB-independent mechanism. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1183-8. Gottschalk AR, Doan A, Nakamura JL, Haas-Kogan DA, Stokoe D. PMID: 15752900.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    82. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. J Neurooncol. 2005 Feb; 71(3):215-22. Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA. PMID: 15735908.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    83. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005; 4(3):202-6. Hsu IC, Cabrera AR, Weinberg V, Speight J, Gottschalk AR, Roach M, Shinohara K. PMID: 16182220.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    84. High-resolution dental magnetic resonance imaging of inferior alveolar nerve responses to the extraction of third molars. Eur Radiol. 2004 Aug; 14(8):1416-20. Kress B, Gottschalk A, Anders L, Stippich C, Palm F, Bähren W, Sartor K. PMID: 15007618.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    85. The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials. Br J Cancer. 2004 Mar 08; 90(5):950-4. Gottschalk AR, Roach M. PMID: 14997188; PMCID: PMC2409615.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):635-44. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, Lowther D, Liu YM, Shinohara K, Verhey LJ, Weinberg V, Roach M. PMID: 14529767.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    87. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res. 2002 May; 8(5):1100-6. Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D, Haas-Kogan DA. PMID: 12006525.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    88. Bell's palsy: what is the prognostic value of measurements of signal intensity increases with contrast enhancement on MRI? Neuroradiology. 2002 May; 44(5):428-33. Kress BP, Griesbeck F, Efinger K, Solbach T, Gottschalk A, Kornhuber AW, Bähren W. PMID: 12012129.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    89. Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link? Alcohol Clin Exp Res. 2001 May; 25(5):717-25. Götz ME, Janetzky B, Pohli S, Gottschalk A, Gsell W, Tatschner T, Ransmayr G, Leblhuber F, Gerlach M, Reichmann H, Riederer P, Böning J. PMID: 11371721.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    90. p27Kip1 is required for PTEN-induced G1 growth arrest. Cancer Res. 2001 Mar 01; 61(5):2105-11. Gottschalk AR, Basila D, Wong M, Dean NM, Brandts CH, Stokoe D, Haas-Kogan DA. PMID: 11280773.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    91. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 2000 Feb 15; 14(4):391-6. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D, Giaccia AJ. PMID: 10691731; PMCID: PMC316386.
      View in: PubMed   Mentions: 238     Fields:    Translation:HumansCells
    92. Mapping of secondary somatosensory cortex activation induced by vibrational stimulation: an fMRI study. Brain Res. 1999 Apr 10; 824(2):291-5. Maldjian JA, Gottschalk A, Patel RS, Pincus D, Detre JA, Alsop DC. PMID: 10196461.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    93. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J Biol Chem. 1997 Apr 11; 272(15):9868-76. Wiesner DA, Kilkus JP, Gottschalk AR, Quintáns J, Dawson G. PMID: 9092523.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    94. Elderly Patients With no Prior Cardiopulmonary Disease Show Ventilation/Perfusion Lung Scan Characteristics That Are Sensitive and Specific for Pulmonary Embolism. Am J Geriatr Cardiol. 1996 Nov; 5(6):36-40. Stein PD, Henry JW, Relyea B, Gottschalk A. PMID: 11416400.
      View in: PubMed   Mentions: 1     Fields:    
    95. Pulmonary embolism among patients with a nearly normal ventilation/perfusion lung scan. Chest. 1996 Aug; 110(2):395-8. Henry JW, Stein PD, Gottschalk A, Raskob GE. PMID: 8697840.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    96. Small perfusion defects in suspected pulmonary embolism. J Nucl Med. 1996 Aug; 37(8):1313-6. Stein PD, Henry JW, Gottschalk A. PMID: 8708763.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    97. Evaluation of individual criteria for low probability interpretation of ventilation-perfusion lung scans. J Nucl Med. 1996 Apr; 37(4):577-81. Stein PD, Relyea B, Gottschalk A. PMID: 8691243.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    98. Scintigraphic lung scans and clinical assessment in critically ill patients with suspected acute pulmonary embolism. Chest. 1996 Feb; 109(2):462-6. Henry JW, Stein PD, Gottschalk A, Relyea B, Leeper KV. PMID: 8620723.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    99. Apoptosis in B lymphocytes: the WEHI-231 perspective. Immunol Cell Biol. 1995 Feb; 73(1):8-16. Gottschalk AR, Quintáns J. PMID: 7768548.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    100. Critical review of ventilation/perfusion lung scans in acute pulmonary embolism. Prog Cardiovasc Dis. 1994 Jul-Aug; 37(1):13-24. Stein PD, Gottschalk A. PMID: 8022983.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    101. Mechanisms of ventilatory periodicities. Ann Biomed Eng. 1993 Sep-Oct; 21(5):537-44. Pack AI, Gottschalk A. PMID: 8239094.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. Am J Cardiol. 1992 May 01; 69(14):1239-41. Stein PD, Terrin ML, Gottschalk A, Alavi A, Henry JW. PMID: 1575198.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    103. Correlation between oscillations in ventilation and frequency content of the electroencephalogram. J Appl Physiol (1985). 1992 Mar; 72(3):985-92. Pack AI, Cola MF, Goldszmidt A, Ogilvie MD, Gottschalk A. PMID: 1568995.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    104. Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol. 1991 Nov 15; 18(6):1452-7. Stein PD, Gottschalk A, Saltzman HA, Terrin ML. PMID: 1939945.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    105. Usefulness of noninvasive diagnostic tools for diagnosis of acute pulmonary embolism in patients with a normal chest radiograph. Am J Cardiol. 1991 May 15; 67(13):1117-20. Stein PD, Alavi A, Gottschalk A, Hales CA, Saltzman HA, Vreim CE, Weg JG. PMID: 2024602.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    106. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J. 1983 Oct; 106(4 Pt 1):638-43. Choi BW, Berger HJ, Schwartz PE, Alexander J, Wackers FJ, Gottschalk A, Zaret BL. PMID: 6613807.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    107. Tomographic gallium-67 citrate scanning. Useful new surveillance for metastatic melanoma. Ann Surg. 1983 Jul; 198(1):102-7. Kirkwood JM, Myers JE, Vlock DR, Neumann R, Ariyan S, Gottschalk A, Hoffer P. PMID: 6859984; PMCID: PMC1352941.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Tomographic gallium-67 citrate scanning: useful new surveillance for metastatic melanoma. Ann Intern Med. 1982 Nov; 97(5):694-9. Kirkwood JM, Myers JE, Vlock DR, Neumann R, Ariyan S, Gottschalk A, Hoffer P. PMID: 7137734.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    109. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med. 1979 Feb 08; 300(6):278-83. Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL. PMID: 759880.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    110. Scintigraphic evaluation of lymphoma: a comparative study of 67Ga-citrate and 111In-Bleomycin. Radiology. 1977 Jun; 123(3):687-94. Bekerman C, Moran EM, Hoffer PB, Hendrix RW, Gottschalk A. PMID: 860022.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    111. The scintillation camera with diverging collimator: physical parameters and a clinical evaluation. Semin Nucl Med. 1971 Apr; 1(2):206-15. Gottschalk A, Usher MS, Turner DA, Polcyn RE, Quinn JL. PMID: 5097788.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. A COMPARISON OF RESULTS OF BRAIN SCANNING USING GA68-EDTA AND THE POSITRON SCINTILLATION CAMERA, WITH HG203-NEOHYDRIN AND THE CONVENTIONAL FOCUSED COLLIMATOR SCANNER. Radiology. 1965 Mar; 84:502-6. GOTTSCHALK A, MCCORMACK KR, ADAMS JE, ANGER HO. PMID: 14280725.
      View in: PubMed   Mentions:    Fields:    
    113. RELATIVE EFFICIENCY OF HIGH-LET RADIATION (BRAGG-PEAK LITHIUM IONS) ON NORMAL RABBIT SKIN, USING INTEGRAL DOSE AS A BASIS FOR COMPARISON. Nature. 1964 Dec 26; 204:1267-8. D ANGIO GJ, LAWRENCE JH, GOTTSCHALK A, LYMAN J. PMID: 14254405.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsPHPublic Health
    114. THE SENSITIVITY OF THE POSITRON SCINTILLATION CAMERA FOR DETECTING SIMULATED BRAIN TUMORS WITH GALLIUM 68-EDTA. Am J Roentgenol Radium Ther Nucl Med. 1964 Jul; 92:174-6. GOTTSCHALK A, ANGER HO. PMID: 14176029.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Alexander's Networks
    Concepts (458)
    Derived automatically from this person's publications.
    _
    Co-Authors (59)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _